echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JAMA Network Open: Vitamin D deficiency in the body may increase an individual's risk of COVID-19.

    JAMA Network Open: Vitamin D deficiency in the body may increase an individual's risk of COVID-19.

    • Last Update: 2020-09-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    SEPTEMBER 10, 2020 // -- In a recent study published in the international journal JAMA Network Open, scientists from the University of Chicago Medical Center and others revealed a link between vitamin D deficiency in the body and the risk of individual SARS-CoV-2 infection after a retrospective study of PATIENT-19 patients.
    Photo Source: David Meltzer, M.D., CC0 Public Domain, says vitamin D plays a vital role in the body's immune system, after previous studies have shown that vitamin D supplements may be effective in reducing the risk of respiratory viral infections, and statistical analysis in this paper suggests that vitamin D supplementation may be promising to treat SARS-CoV-2 infections. In the
    article, researchers studied 489 patients who had been tested for the body's vitamin D levels in the year prior to their diagnosis of COVID-19, and found that untreated vitamin D deficiency patients were almost twice as likely to develop COVID-19 as individuals with adequate vitamin D levels.
    researchers point out that half of the U.S. population is deficient in vitamin D, and that African-Americans, Hispanics, and people living in winter areas such as Chicago, where adequate sunlight is difficult to get, understand whether treating vitamin D deficiency can alter an individual's risk of COVID-19, which is important for the health of people everywhere, nationally and globally, and is not expensive, widely available and safe to take. Meltzer, a
    researcher, said more in-depth studies are needed later to determine whether additional vitamin D supplementation can reduce an individual's risk of COVID-19 or a potentially serious disease, and the researchers highlighted how the study uses a variety of strategies to make vitamin D supplementation beneficial to specific populations, and researchers have conducted several clinical trials at the University of Chicago Medical Center.
    () Original source: David O. Meltzer, MD, PhD1; Thomas J. Best, PhD2; Hui Zhang, PhD2; et al Association of Vitamin D Status and Other Clinical Features With COVID-19 Test Results, JAMA Netw Open. 2020;3 (9): e2019722. doi: 10.1001 / jamanetworkopen.2020.19722.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.